期刊论文详细信息
NEUROPHARMACOLOGY 卷:104
Purinergic mechanisms in neuroinflammation: An update from molecules to behavior
Review
Beamer, Edward1  Goloncser, Flora1  Horvath, Gergely1  Beko, Katinka1  Otrokocsi, Lilla1  Kovanyi, Bence1  Sperlagh, Beata1 
[1] Hungarian Acad Sci, Inst Expt Med, Mol Pharmacol Lab, POB 67, H-1450 Budapest, Hungary
关键词: Neuroinflammation;    NLRP3 inflammasome;    Cytokines;    P2X receptor;    P2Y receptor;    P1 receptor;   
DOI  :  10.1016/j.neuropharm.2015.09.019
来源: Elsevier
PDF
【 摘 要 】

The principle functions of neuroinflammation are to limit tissue damage and promote tissue repair in response to pathogens or injury. While neuroinflammation has utility, pathophysiological inflammatory responses, to some extent, underlie almost all neuropathology. Understanding the mechanisms that control the three stages of inflammation (initiation, propagation and resolution) is therefore of critical importance for developing treatments for diseases of the central nervous system. The purinergic signaling system, involving adenosine, ATP and other purines, plus a host of P1 and P2 receptor subtypes, controls inflammatory responses in complex ways. Activation of the inflammasome, leading to release of pro-inflammatory cytokines, activation and migration of microglia and altered astroglial function are key regulators of the neuroinflammatory response. Here, we review the role of P1 and P2 receptors in mediating these processes and examine their contribution to disorders of the nervous system. Firstly, we give an overview of the concept of neuroinflammation. We then discuss the contribution of P2X, P2Y and P1 receptors to the underlying processes, including a discussion of cross-talk between these different pathways. Finally, we give an overview of the current understanding of purinergic contributions to neuroinflammation in the context of specific disorders of the central nervous system, with special emphasis on neuropsychiatric disorders, characterized by chronic low grade inflammation or maternal inflammation. An understanding of the important purinergic contribution to neuroinflammation underlying neuropathology is likely to be a necessary step towards the development of effective interventions. (C) 2015 Elsevier Ltd. All rights reserved.

【 授权许可】

Free   

【 预 览 】
附件列表
Files Size Format View
10_1016_j_neuropharm_2015_09_019.pdf 762KB PDF download
  文献评价指标  
  下载次数:10次 浏览次数:0次